Regulatory & Scientific Challenge: Earlier Inclusion of Children In Drug Development Entry into Man Proof of Concept (PoC) Patent-protected Market Registration 1st Country Phase II+III Basic Research Patent Expiry  Generic Competition FDA: Early dialogue recommended; Ped Plan mandatory at submission EU Pediatric Investigation Plan (PIP): mandatory at end of human PK klaus.rose@klausrose.net 12